Sunny Pharmtech Inc.
6676
Rank in Stocks
#23742
Based in Taoyuan, Taiwan, and established in 1994, Sunny Pharmtech Inc. focuses... Based in Taoyuan, Taiwan, and established in 1994, Sunny Pharmtech Inc. focuses on the entire lifecycle of pharmaceutical products, from initial research and development to manufacturing and global sales. Its operations encompass both active pharmaceutical ingredients (APIs) and finished medicinal products. The company's extensive product range includes: A lidocaine ointment, which functions as an anesthetic lubricant for intubation procedures and offers temporary relief from discomfort associated with minor burns, sunburn, skin abrasions, and insect stings. Cyanocobalamin injections, prescribed to treat vitamin B12 deficiency and pernicious anemia caused by malabsorption issues. Nitrofurantoin capsules, used in the treatment of urinary tract infections. Aminocaproic acid tablets, indicated for managing certain blood disorders and conditions involving excessive proteolytic enzyme activity. Carboprost tromethamine injections, utilized in therapeutic abortions and to address postpartum hemorrhage.
Share Price
$0.2310722
Last synced: 2026-11-10
Market Cap
$39.21M
Change (1 day)
-5.60%
Change (1 year)
-49.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sunny Pharmtech Inc. (6676)
Category
Healthcare
Operating Margin for Sunny Pharmtech Inc. (6676)
Operating Margin as of November 2026 TTM: -150.02%
According to Sunny Pharmtech Inc.'s latest financial reports, its current operating margin (TTM) is -150.02%. At the end of 2025 the company had an operating margin of -125.50%.
Operating Margin history for Sunny Pharmtech Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -150.02% | 19.54% |
| 2025 | -125.50% | 221.88% |
| 2024 | -38.99% | 131.95% |
| 2023 | -16.81% | -67.78% |
| 2022 | -52.18% | -28.55% |
| 2021 | -73.03% | 312.60% |
| 2020 | -17.70% | -80.61% |
| 2019 | -91.28% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.26% |
US
|
|
| -149.01% | -99.01% |
US
|
|
| 25.57% | -100.17% |
AU
|
|
| 31.23% | -100.21% |
BE
|
|
| 29.35% | -100.20% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Sunny Pharmtech Inc.'s operating margin
What is Sunny Pharmtech Inc.'s operating margin?
Sunny Pharmtech Inc.'s operating margin is -150.02%, as of Nov 2026.
What was Sunny Pharmtech Inc.'s operating margin in 2025?
In 2025, Sunny Pharmtech Inc.'s operating margin was -125.50%, compared with -38.99% in 2024.
How has Sunny Pharmtech Inc.'s operating margin changed since 2020?
From 2020 to 2025, Sunny Pharmtech Inc.'s operating margin was highest in 2023 (-16.81%) and lowest in 2025 (-125.50%).
How does Sunny Pharmtech Inc.'s operating margin compare with similar companies?
Sunny Pharmtech Inc.'s operating margin (-150.02%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.